Objective: To evaluate the hypothesis that white coat hypertension (WCH) represents a prehypertensive state by correlating ambulatory blood pressure monitoring (ABPM) results with BP response to treadmill exercise (TE) and echocardiographic measurement of left ventricular mass index (LVMI) in children with high blood pressure (HBP).
Study Design: We evaluated 119 consecutive children age 6 to 18 years (mean = 13.3 years; 65% male) referred for HBP. Office systolic BP (SBP) exceeded the 95th percentile for age/sex/height in all of the children; 10% also had elevated diastolic BP (DBP). WCH was defined as elevated office SBP +/- elevated DBP with normal mean awake ABPM-SBP. ABPM classified 62 subjects as having WCH and 57 as having HBP.
Results: Office BP did not differ between the 2 groups. As defined, awake ABPM-SBP was lower in the WCH group (males: HBP, 142 +/- 12 vs WCH, 124 +/- 5; females: HBP, 137 +/- 8 vs WCH, 121 +/- 5). Awake and asleep DBP and asleep SBP were significantly lower in the WCH group. On TE, maximal SBP exceeded norms for age/sex/body surface area in 63% of the HBP group and 38% of the WCH group. LVMI exceeded the 95th percentile for age/sex in 59% of the males and 90% of the females in the HBP group and in 33% of the males and 36% of the females in the WCH group.
Conclusions: Exaggerated exercise BP and/or increased LVMI in 62% of those subjects with WCH suggest that this diagnosis in children may represent a prehypertensive state.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpeds.2007.01.033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Different phenotypes of hypertension and associated cardiovascular and all-cause mortality: a systematic review and meta-analysis.
Egypt Heart J
December 2024
Department of Internal Medicine, HIND Institute of Medical Sciences, Barabanki, India.
Background: Hypertension is a leading cause of premature mortality and morbidity. Recent guidelines advocate for out-of-office blood pressure monitoring, including ambulatory and home BP monitoring, to better identify hypertension phenotypes like masked hypertension, white coat hypertension, and sustained hypertension. However, clinical inertia persists due to a lack of robust evidence on the effectiveness of screening these phenotypes and their association with cardiovascular and all-cause mortality.
View Article and Find Full Text PDFPersonal tutoring black nursing students: A qualitative study of the experiences of students and tutors.
Nurse Educ Today
December 2024
Faculty of Education and Society, University College London, 20 Bedford Way, London, WCH 0AL, United Kingdom.
Article Synopsis
- Personal tutoring at university aims to give pastoral care to students, but there's a lack of research on the specific needs of Black nursing students.
- The study seeks to explore their perceptions and experiences of personal tutor support, identifying both challenges and facilitators.
- Results show that while some students had positive experiences, many felt their tutors did not provide enough support, highlighting themes around cultural competency, belonging, and the need for resilience.
Participation but not success in youth and junior World Championships is important for overall ranking in the biathlon World Cup during adult age.
Front Sports Act Living
November 2024
Swedish Winter Sports Research Centre, Department of Health Sciences, Mid Sweden University, Östersund, Sweden.
Purpose: The aim of this study was to investigate if competition rank in the youth (16-19 years) and junior (20-22 years) World Championships (WCH) and age of the athlete when reaching certain World Cup (WC) performance milestones (debut and top 40, 15, 6 and 3) were related to future World Cup total (WCT) performance.
Methods: All data was obtained from the International Biathlon Unions database. The biathletes ranked top 30 in the WCT (82 men, 98 women) during 10 consecutive competition seasons were selected for further analysis.
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Lancet Oncol
December 2024
British Columbia Cancer Agency, Vancouver, BC, Canada.
Background: Alpelisib, a PI3Kα-selective inhibitor and degrader, plus fulvestrant showed efficacy in hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer in SOLAR-1; limited data are available in the post-cyclin-dependent kinase 4/6 inhibitor setting. BYLieve aimed to assess alpelisib plus endocrine therapy in this setting in three cohorts defined by immediate previous treatment; here, we report results from cohort A.
Methods: This ongoing, phase 2, multicentre, open-label, non-comparative study enrolled patients with hormone receptor-positive, HER2-negative, advanced breast cancer with tumour PIK3CA mutation, following progression on or after previous therapy, including CDK4/6 inhibitors, from 114 study locations (cancer centres, medical centres, university hospitals, and hospitals) in 18 countries worldwide.
Pacing strategies of 10 km elite open water swimmers with enhanced temporal resolution: World Swimming Championships Budapest 2022.
J Sports Sci
November 2024
Sports Department, Universidad Politécnica de Madrid, Madrid, Spain.
Article Synopsis
- - The study focuses on the pacing strategies and race tactics of elite open water swimmers, emphasizing the impact of enhanced data collection during the 2022 World Championships.
- - Researchers analyzed data from 116 swimmers, looking at average velocity, stroke rate, and positions at 17 timing points throughout a 10 km race, revealing that successful swimmers had less conservative pacing compared to past events.
- - Findings indicate a shift in race strategies, with notable variations in pacing and more aggressive finishes, challenging earlier assumptions based on less precise race data.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!